Liwei Dong

Title: Liwei Dong: Innovator in Monoclonal Antibody Research

Introduction

Liwei Dong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work is crucial for advancing therapeutic options in various medical conditions.

Latest Patents

Liwei Dong holds a patent for the invention titled "P28GANK monoclonal antibody and peptides for preparation thereof and use thereof." This invention provides the sequences of two polypeptides comprising the amino acid sequences as shown in SEQ ID NO:1 and SEQ ID NO:2. These sequences can be utilized for the preparation of monoclonal antibodies against human p28. The invention also details the monoclonal antibodies against human p28 and their applications in medical treatments. He has 1 patent to his name.

Career Highlights

Liwei Dong is affiliated with the Second Military Medical University, which is part of the People's Liberation Army. His role at this esteemed institution allows him to engage in cutting-edge research and contribute to advancements in medical science.

Collaborations

Liwei Dong has collaborated with notable colleagues, including Hongyang Wang and Yao Liang Chen. These partnerships enhance the scope and impact of his research endeavors.

Conclusion

Liwei Dong's innovative work in monoclonal antibody research exemplifies the importance of scientific inquiry in medicine. His contributions are paving the way for new therapeutic strategies and improving patient outcomes.